Nrg Oncology Cc001: A Phase Iii Trial Of Hippocampal Avoidance (Ha) In Addition To Whole-Brain Radiotherapy (Wbrt) Plus Memantine To Preserve Neurocognitive Function (Ncf) In Patients With Brain Metastases (Bm).